Ka Hoʻololi ʻana o ke Kine Hoʻohui TEL-AML1 Kanaka

Wehewehe Pōkole:

Hoʻohana ʻia kēia pahu hana no ka ʻike qualitative o ka TEL-AML1 fusion gene i loko o nā hāpana iwi kanaka in vitro.


Nā kikoʻī huahana

Nā Lepili Huahana

Inoa huahana

Pahu ʻIke Hoʻololi Gene Fusion TEL-AML1 Kanaka HWTS-TM016 (Fluorescence PCR)

ʻAlapia

ʻO ka leukemia lymphoblastic acute (ALL) ka maʻi ʻino maʻamau i ka wā kamaliʻi. I nā makahiki i hala iho nei, ua loli ka leukemia acute (AL) mai ke ʻano MIC (morphology, immunology, cytogenetics) i ke ʻano MICM (hoʻohui ʻia o ka hoʻāʻo ʻana i ka biology molecular). I ka makahiki 1994, ua ʻike ʻia ua hoʻokumu ʻia ka TEL fusion i ka wā kamaliʻi e ka nonrandom chromosomal translocation t(12;21)(p13;q22) ma ka B-lineage acute lymphoblastic leukemia (ALL). Mai ka ʻike ʻia ʻana o ka gene fusion AML1, ʻo ka gene fusion TEL-AML1 ke ala maikaʻi loa e hoʻoholo ai i ka prognosis o nā keiki me ka leukemia lymphoblastic acute.

Kanal

ʻOhana ʻO ka gene fusion TEL-AML1
ROX

Mana Kūloko

Nā Palena ʻenehana

Ka Waihona

≤-18℃

Ola papa 9 mahina
ʻAno Laʻana hāpana iwi
Ct ≤40
CV <5.0%
LoD 1000 Kope/mL
Kūlana kikoʻī ʻAʻohe cross-reactivity ma waena o nā kits a me nā genes fusion ʻē aʻe e like me BCR-ABL, E2A-PBX1, MLL-AF4, AML1-ETO, PML-RARa fusion genes.
Nā Mea Hana Pili Nā ʻōnaehana Biosystems i hoʻopili ʻia 7500 Nā ʻōnaehana PCR Manawa Maoli

Nā ʻōnaehana PCR manawa maoli wikiwiki Biosystems i hoʻopili ʻia 7500

Nā ʻōnaehana PCR Manawa Maoli QuantStudio®5

Nā ʻōnaehana PCR Manawa Maoli SLAN-96P

ʻŌnaehana PCR Manawa Maoli LightCycler®480

ʻŌnaehana ʻIke PCR Manawa Maoli LineGene 9600 Plus

MA-6000 Mea Hoʻopololei Wela Manawa Maoli

ʻŌnaehana PCR Manawa Maoli BioRad CFX96

ʻŌnaehana PCR Manawa Maoli BioRad CFX Opus 96

Kahe Hana

RNAprep Pure Blood Total RNA Extraction Kit (DP433).


  • Ma mua:
  • Aʻe:

  • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou